Holding(s) in Company

Dechra Pharmaceuticals PLC 20 January 2006 Dechra Pharmaceuticals PLC ('the Company') Holding(s) in Company The Company was notified 20 January 2006 by Barclays PLC that through the legal entities of Barclays Global Investors Ltd, Barclays Capital Securities Ltd, Barclays Life Assurance Co Ltd and Gerrard Ltd, Barclays PLC has a notifiable interest in 2,843,036 ordinary shares of 1p each in the Company ('Ordinary Shares'), representing approximately 5.53 per cent. of the Company's issued ordinary share capital. These Ordinary Shares are registered as follows: Registered Holder Ordinary Shares Barclays Capital Nominees Limited 571,658 Chase Nominees Ltd a/c 16376 28,830 Chase Nominees Ltd a/c 21359 110,792 Chase Nominees Ltd a/c 28270 18,742 Chase Nominees Ltd a/c 28270 27,222 JP Morgan (BGI Custody) a/c 16341 36,065 JP Morgan (BGI Custody) a/c 16341 62,361 JP Morgan (BGI Custody) a/c 16344 21,055 JP Morgan (BGI Custody) a/c 16345 35,216 JP Morgan (BGI Custody) a/c 16400 386,797 JP Morgan (BGI Custody) a/c 16480 1,273,190 JP Morgan (BGI Custody) a/c 16482 240,248 JP Morgan (BGI Custody) a/c 18409 29,412 R C Greig Nominees Limited a/c 1,448 Total 2,843,036 20 January 2006 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings